Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms

DSpace Repository

Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms

Author: Kampa-Schittenhelm, Kerstin Maria; Heinrich, Michael Charles; Akmut, Figen; Doehner, Hartmut; Doehner, Konstanze; Schittenhelm, Marcus Matthias
Tübinger Autor(en):
Kampa-Schittenhelm, Kerstin Maria
Akmut, Figen
Schittenhelm, Marcus Matthias
Published in: Molecular Cancer (2013), Bd. 12, Article 19
Verlagsangabe: Biomed Central Ltd
Language: English
Full text: http://dx.doi.org/10.1186/1476-4598-12-19
ISSN: 1476-4598
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)